| Literature DB >> 34947042 |
Fayaz Ahmad Mohiddin1, Nazir A Bhat2, Shabir H Wani2, Arif H Bhat1, Mohammad Ashraf Ahanger3, Asif B Shikari4, Najeebul Rehman Sofi4, Shugufta Parveen2, Gazala H Khan4, Zaffar Bashir5, Pavla Vachova6, Sabry Hassan7, Ayman El Sabagh8.
Abstract
Rice blast is considered one of the most important fungal diseases of rice. Although diseases can be managed by using resistant cultivars, the blast pathogen has successfully overcome the single gene resistance in a short period and rendered several varieties susceptible to blast which were otherwise intended to be resistant. As such, chemical control is still the most efficient method of disease control for reducing the losses caused due to diseases. Field experiments were conducted over two successive years, 2018 and 2019, in temperate rice growing areas in northern India. All the fungicides effectively reduced leaf blast incidence and intensity, and neck blast incidence under field conditions. Tricyclazole proved most effective against rice blast and recorded a leaf blast incidence of only 8.41%. Among the combinations of fungicides, azoxystrobin + difenoconazole and azoxystrobin + tebuconazole were highly effective, recording a leaf blast incidence of 9.19 and 10.40%, respectively. The chemical combination mancozeb + carbendazim proved less effective in controlling the blast and it recorded a disease incidence of 27.61%. A similar trend was followed in neck blast incidence with tricyclazole, azoxystrobin + difenoconazole, and azoxystrobin + tebuconazole showing the highest levels of blast reductions. It is evident from the current study that the tested fungicide combinations can be used as alternatives to tricyclazole which is facing the challenges of fungicide resistance development and other environmental concerns and has been banned from use in India and other countries. The manuscript may provide a guideline of fungicide application to farmers cultivating susceptible varieties of rice.Entities:
Keywords: fungicides; leaf blast; management; neck blast; rice
Year: 2021 PMID: 34947042 PMCID: PMC8707660 DOI: 10.3390/jof7121060
Source DB: PubMed Journal: J Fungi (Basel) ISSN: 2309-608X
Figure 1Rice blast symptoms in the field: (a) initial appearance of blast lesions (arrow); (b) characteristic diamond-shaped blast lesions showing vertical extension (arrow); (c) coalescing of blast lesions; (d) rice field of Mushk Budji cultivar heavily infested with rice blast. (Source: photographs are from our laboratory).
Figure 2Cultural and morphological characterization of Pyricularia oryzae (fungus) causing blast disease of rice (a). Initial growth of fungus on PDA (b). Various spores of fungus (c). Growth of fungus after 20 days on culture plate (d) Single spore of fungus (Source: photographs are from our laboratory).
Disease rating scale (IRRI, 2013).
| Category | Symptoms |
|---|---|
| 0 | No lesion |
| 1 | Small brown specks of pinhead size without sporulating center |
| 2 | Small roundish to slightly elongated, necrotic grey spots, about 1–2 mm in diameter with a distinct brown margin and lesions are mostly found on the lower leaves |
| 3 | Lesion type is the same as in scale 2, but significant number of lesions are on the upper leaves |
| 4 | Typical sporulating blast lesions, 3 mm of longer, infecting less than 2% of the leaf area |
| 5 | Typical blast lesions infecting 2–10% of the leaf area |
| 6 | Blast lesions infecting 11–25% leaf area |
| 7 | Blast lesions infecting 26–50% leaf area |
| 8 | Blast lesions infecting 51–75% leaf area |
| 9 | More than 75% of leaf area affected |
Figure 3Percent of disease control to leaf blast incidence: (a) 2018; (b) 2019, leaf blast severity; (c) 2018; (d) 2019 and nodal blast incidence; (e) 2018; (f) 2019. Bars correspond to the retransformed means and the upper and lower 95% confidence intervals of the mean are shown as error bars.T1 = flusilazole + carbendazim, T2 = azoxystrobin+ difenoconazole, T3 = azoxystrobin + tebuconazole, T4 = tricyclazole + mancozeb, T5 = zineb + hexaconazole, T6 = trifloxystrobin + tebuconazole, T7 = mancozeb + carbendazim, T8 = fluxapyroxad + epoxiconazole, T9 = tricyclazole, and T10 = Control (Cntrl).
Field efficacy of various fungicides on the severity of rice blast disease (2018).
| Active Ingredient | Fungicide | Chemical Group | Concentration per Liter of Water | Leaf Blast | Neck Blast | Leaf Blast |
|---|---|---|---|---|---|---|
| Flusilazole 12.5% + | Lustre | triazole plus | 1 mL | 21.88 ± 0.69 b | 35.27 ± 0.76 c | 7.45 ± 0.56 c |
| Azoxystrobin 18.2% + difenconazole 11.4% SC | Amistar® Top | triazole plus strobilurin | 1 mL | 8.97 ± 0.71 e | 12.56 ± 0.40 i | 2.53 ± 0.55 g |
| Azoxystrobin 11% + | Custodia | triazole plus strobilurin | 1.5 mL | 9.57 ± 0.57 e | 15.52 ± 1.25 h | 3.00 ± 0.20 f,g |
| Tricyclazole 18% + | Merger | triazole plus | 2.5 g | 11.67 ± 0.64 d | 18.8 ± 0.54 g | 3.89 ± 0.35 e,f |
| Zineb 68% + hexaconazole 4% | Avatar | triazole plus | 2.5 g | 17.09 ± 0.56 c | 28.12 ± 0.76 e | 6.21 ± 0.46 d |
| Trifloxystrobin 25% + tebuconazole 50% WG | Nativo® | triazole plus strobilurin | 0.4 g | 11.54 ± 0.53 d | 20.19 ± 0.80 f | 4.89 ± 0.23 e |
| Mancozeb 50% + Carbendazim 25% WS | Sprint® | dithiocarbamate plus benzimidazole | 2.5 g | 12.3 ± 0.96 d | 36.55 ± 0.68 b | 10.05 ± 1.07 b |
| Fluxapyroxad 62.5 g/L + epoxiconazole 62.5 g/L EC | Adexar® | pyrazole-carboximide plus triazole | 1.5 mL | 22.57 ± 1.54 b | 30.83 ± 0.72 d | 7.61 ± 0.45 c |
| Tricyclazole 75% | Force 11TM | melanin biosynthesis inhibitors—reductase | 0.6 g | 6.86 ± 0.90 f | 12.22 ± 0.35 i | 2.95 ± 0.10 f,g |
| Water (Control) | - | - | - | 64.92 ± 0.52 a | 87.50 ± 1.47 a | 26.24 ± 1.13 a |
Rice blast severity on a scale of 0–9, where 0 = no symptoms, and 9 = most severe (IRRI, 2013). Means ± standard deviations in each column followed by different superscripted letters are significantly different at p < 0.05 based on DMRT.
Field efficacy of various fungicides on the severity of rice blast disease (2019).
| Active Ingredient | Fungicide | Chemical Group | Concentration per Liter of Water | Leaf Blast | Neck Blast | Leaf Blast |
|---|---|---|---|---|---|---|
| Flusilazole 12.5% + carbendazim 25% SC | Lustre | triazole plus | 1 mL | 22.64 ± 0.94 c,b | 36.23 ± 1.50 b | 8.76 ± 0.80 c |
| Azoxystrobin 18.2% + difenconazole 11.4% SC | Amistar® Top | triazole plus | 1 mL | 9.19 ± 1.35 f | 14.74 ± 2.21 f | 3.43 ± 0.46 f |
| Azoxystrobin 11% + tebuconazole 18.3% SC | Custodia | triazole plus | 1.5 mL | 10.40 ± 0.60 e,f | 16.64 ± 0.97 f | 3.82 ± 0.27 e,f |
| Tricyclazole 18% + mancozeb 62% WP | Merger | triazole plus | 2.5 g | 12.49 ± 0.50 e | 20.01 ± 0.74 e | 4.93 ± 0.20 e |
| Zineb 68% + hexaconazole 4% | Avatar | triazole plus | 2.5 g | 18.61 ± 1.11 d | 29.51 ± 1.34 d | 6.72 ± 0.42 d |
| Trifloxystrobin 25% + tebuconazole 50% WG | Nativo® | triazole plus | 0.4 g | 12.43 ± 0.56 e | 19.92 ± 0.86 e | 4.68 ± 0.87 e,f |
| Mancozeb 50% + Carbendazim 25% WS | Sprint® | dithiocarbamate plus | 2.5 g | 27.61 ± 0.75 b | 38.31 ± 1.36 b | 10.78 ± 0.58 b |
| Fluxapyroxad 62.5 g/L + epoxiconazole 62.5 g/L EC | Adexar® | pyrazole-carboximide plus | 1.5 mL | 23.22 ± 0.39 c | 33.22 ± 0.39 c | 8.84 ± 0.76 c |
| Tricyclazole 75% | Force 11TM | melanin biosynthesis inhibitors—reductase | 0.6 g | 8.41 ± 0.80 f | 14.10 ± 0.97 f | 3.56 ± 0.54 f |
| Water (Control) | - | - | - | 66.78 ± 7.04 a | 89.14 ± 4.22 a | 27.98 ± 1.72 a |
Rice blast severity on a scale of 0–9, where 0 = no symptoms, and 9 = most severe (IRRI, 2013). Means ± standard deviations in each column followed by different superscripted letters are significantly different at p < 0.05 based on DMRT.
Effect of fungicide treatments on the yield of Mushk Budji rice in 2018 and 2019.
| Active Ingredient | Fungicide | Chemical Group | Concentration | Yield | Yield |
|---|---|---|---|---|---|
| Flusilazole 12.5% + carbendazim 25% SC | Lustre | triazole plus | 1 mL | 44.41 ± 3.53 d | 45.73 ± 1.88 e |
| Azoxystrobin 18.2% + difenconazole 11.4% SC | Amistar® Top | triazole plus strobilurin | 1 mL | 63.62 ± 3.20 a | 60.30 ± 2.21 b |
| Azoxystrobin 11% + tebuconazole 18.3% SC | Custodia | triazole plus strobilurin | 1.5 mL | 62.43 ± 3.48 a | 60.29 ± 3.30 b |
| Tricyclazole 18% + mancozeb 62% WP | Merger | triazole plus | 2.5 g | 56.09 ± 2.77 b | 54.23 ± 3.18 c |
| Zineb 68% + hexaconazole 4% | Avatar | triazole plus | 2.5 g | 51.54 ± 3.35 c | 50.27 ± 2.31 d |
| Trifloxystrobin 25% + tebuconazole 50% WG | Nativo® | triazole plus strobilurin | 0.4 g | 54.50 ± 2.94 b,c | 53.83 ± 2.73 c,d |
| Mancozeb 50% + Carbendazim 25% WS | Sprint® | dithiocarbamate plus | 2.5 g | 41.80 ± 3.15 d | 38.96 ± 3.73 f |
| Fluxapyroxad 62.5 g/L + epoxiconazole 62.5 g/L EC | Adexar® | pyrazole-carboximide plus triazole | 1.5 mL | 41.99 ± 3.53 d | 43.76 ± 2.80 e |
| Tricyclazole 75% | Force 11TM | melanin biosynthesis inhibitors—reductase | 0.6 g | 65.85 ± 3.40 a | 67.73 ± 3.90 a |
| Water (Control) | - | - | - | 31.75 ± 2.50 e | 32.08 ± 3.27 g |
Means ± standard deviations in each column followed by different superscripted letters are significantly different at p < 0.05 based on DMRT.